KS

Kanchan Singh

Active Director Director DIN 11175645
DIN 11175645 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanchan Singh

Data last updated:

Kanchan Singh is a Director at Mydwaar Private Limited (since 2026) and Director at Mydwaar Pharma Private Limited (since 2025).

DIN 11175645
Primary Designation Director
First Appointment 30 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mydwaar Private Limited U62011DC2026PTC468961
Director17 Feb 20262026Active
Mydwaar Pharma Private Limited U47721DL2025PTC450920
Director30 Jun 20252025Active

Board colleagues of Kanchan Singh

Directorship timeline

Open interactive timeline →
Mydwaar Pharma Private Limited
Mydwaar Private Limited
Premium access

Shareholding and investment profile for Kanchan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchan Singh

Kanchan Singh currently holds 2 directorships: Mydwaar Private Limited (Director, since 17 Feb 2026); Mydwaar Pharma Private Limited (Director, since 30 Jun 2025).

Kanchan Singh was first appointed on 30 Jun 2025 as Director at Mydwaar Pharma Private Limited. The most recent appointment on record is 17 Feb 2026 at Mydwaar Private Limited.

The current boards of Kanchan Singh's companies include Priti Kumari (Mydwaar Private Limited), Tarun Kumar Keshari (Mydwaar Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available